Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
85 studies found for:    Heart Block | Open Studies | NIH, U.S. Fed
Show Display Options
Rank Status Study
21 Recruiting Randomized Endo-Vein Graft Prospective
Condition: Coronary Artery Bypass Grafting
Intervention: Procedure: Vein Harvesting Procedures
22 Recruiting Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis
Condition: Lymphangioleiomyomatosis
Interventions: Drug: albuterol inhaler;   Procedure: PFT;   Drug: albuterol nebulizer
23 Recruiting Randomized Controlled Trial of Group Prevention Coaching
Condition: Cardiovascular Disease
Intervention: Behavioral: Problem Solving
24 Recruiting Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)
Condition: Healthy Subjects
Intervention:
25 Recruiting Longitudinal Observational Study of Severe Asthma
Condition: Asthma
Intervention:
26 Recruiting Using Practice Facilitation in Primary Care Settings to Reduce Risk Factors for Cardiovascular Disease
Conditions: Cardiovascular Disease;   High Blood Pressure
Interventions: Behavioral: Million Hearts ABCS 6 Months;   Behavioral: Million Hearts ABCS 9 Months;   Behavioral: Million Hearts ABCS 12 Months;   Behavioral: Million Hearts ABCS 15 Months;   Behavioral: Standard Care Regimen 9 Months;   Behavioral: Standard Care Regimen 12 Months;   Behavioral: Standard Care Regimen 15 Months;   Behavioral: Standard Care Regimen 18 Months;   Behavioral: Standard Care Regimen 21 Months;   Behavioral: Standard Care Regimen 24 Months;   Behavioral: Standard Care Regimen 27 Months;   Behavioral: Follow Up Post Intervention 21 Months;   Behavioral: Follow Up Post Intervention 24 Months;   Behavioral: Follow Up Post Intervention 27 Months;   Behavioral: Follow Up Post Intervention 30 Months;   Behavioral: Follow Up Post Intervention 33 Months
27 Recruiting Clinical and Basic Investigations Into Known and Suspected Congenital Disorders of Glycosylation
Condition: Congenital Disorders of Glycosylation
Intervention:
28 Recruiting A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer
Conditions: Ovarian Cancer;   Breast Cancer;   Prostate Cancer
Intervention: Drug: LY2606368
29 Recruiting Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma
Condition: Sarcoma, Alveolar Soft Part
Intervention: Drug: AZD2171
30 Recruiting Combination Nilotinib and Paclitaxel in Adults With Relapsed Solid Tumors
Condition: Solid Tumors
Intervention: Drug: Nilotinib + Paclitaxel
31 Recruiting Bisnorcymserine in Healthy Adult Volunteers
Condition: Alzheimer's Disease
Intervention: Drug: BNC
32 Recruiting A Novel Compound for Alcoholism Treatment: A Translational Strategy
Condition: Alcoholism
Interventions: Drug: PF-05190457;   Behavioral: MI-VF;   Other: Placebo;   Other: Counseling
33 Not yet recruiting Deep Brain Stimulation Surgery for Focal Hand Dystonia
Conditions: Dystonia;   Focal Dystonia;   Musician's Dystonia
Intervention: Procedure: DBS surgery
34 Recruiting Study of Alkaptonuria
Condition: Alkaptonuria
Intervention:
35 Recruiting Mifepristone for Metabolic Syndrome
Conditions: Endocrine Disease;   Diabetes
Intervention: Drug: Mifepristone
36 Recruiting Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma
Conditions: Adult Ependymoblastoma;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Adult Medulloblastoma;   Adult Mixed Glioma;   Adult Oligodendroglial Tumors;   Adult Pineoblastoma;   Adult Supratentorial Primitive Neuroectodermal Tumor (PNET)
Interventions: Radiation: radiation therapy;   Drug: temozolomide;   Drug: plerixafor;   Other: laboratory biomarker analysis;   Other: pharmacological study
37 Recruiting Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis
Condition: Coronary Artery Bypass
Interventions: Drug: Prasugrel;   Drug: Placebo
38 Recruiting Radiation-Free Heart Catheterization Using MRI
Conditions: Aortic Coarctation;   Cardiomyopathy;   Atrial Septal Defect;   Aortic Stenosis;   Post Heart Transplant Catheter Procedure;   Patent Ductus Arteriosus
Interventions: Procedure: MRI guided cardiac catheterization;   Device: Magnetic resonance imaging
39 Recruiting Liposomal Cytarabine-Daunorubicin CPX-351, Fludarabine Phosphate, Cytarabine, and Filgrastim in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia
Conditions: Recurrent Childhood Acute Myeloid Leukemia;   Secondary Acute Myeloid Leukemia;   Therapy-Related Acute Myeloid Leukemia
Interventions: Drug: Cytarabine;   Biological: Filgrastim;   Drug: Fludarabine Phosphate;   Other: Laboratory Biomarker Analysis;   Drug: Liposomal Cytarabine-Daunorubicin CPX-351;   Other: Pharmacological Study
40 Recruiting Pathophysiology of Orthostatic Intolerance
Conditions: Tachycardia;   Postural Orthostatic Tachycardia Syndrome
Interventions: Radiation: DAXOR;   Procedure: QSweat;   Drug: Intrinsic Heart Rate

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.